Xenetic Biosciences, Inc.
AED12.54
AED
Last updated on --.
24h volume13.57K
24h highest12.6157 AED
24h lowest11.5323 AED
24h Price movement+1.04%
XBIO recent prices
24 Hours
+1.04%+AED0.12854
30 days
+9.22%+AED1.046
60 days
+6.97%+AED0.80799
90 days
+47.38%+AED3.984
Key data
Previous close12.4137 AED
Market cap26.51M AED
Volume13.57K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-3.5992 AED
Net income (FY)-8.21M AED
Revenue (FY)5.13M AED
Last report dateMay 12, 2026
About Xenetic Biosciences, Inc.
HeadquartersFRAMINGHAM
Employees (FY)2.00
Revenue per employee (FY)2.57M AED
Net income per employee (FY)-4.10M AED
Listed onNasdaq
XBIO conversion tables
 |  |
|---|---|
| 0.5 XBIO | 6.271 AED |
| 1 XBIO | 12.54 AED |
| 5 XBIO | 62.71 AED |
| 10 XBIO | 125.42 AED |
| |
|---|---|
| 0.5 AED | 0.039865 XBIO |
| 1 AED | 0.07973 XBIO |
| 5 AED | 0.39865 XBIO |
| 10 AED | 0.7973 XBIO |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
XBIO is trading at AED12.54, +1.04% over the last 24 hours. Track live moves on the price chart at the top of this page.
The XBIO stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. XBIO is currently trading at AED12.54, +1.04% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on XBIO price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. XBIO's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from XBIO; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against XBIO's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Xenetic Biosciences, Inc.'s market cap is currently 26.51M AED. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume13.57K
24h highest12.6157 AED
24h lowest11.5323 AED
24h Price movement+1.04%
Start trade with XBIO Perpetual
Sign up to trade